THE ROLE OF RECOMBINANT HUMAN ERYTHROPOIETIN IN MANAGEMENT OF CRITICALLY ILL PATIENTS
Sameh Bashir AL-Hewety;
Abstract
Summary
Erythropoietin (EPO) is the principal hematopoietic hormone produced by the kidney and the liver in fetuses, regulates mammalian erythropoiesis. rHuEPO may also have additional therapeutic effects in vivo, such as recruitment of vascular
Erythropoietin (EPO) is the principal hematopoietic hormone produced by the kidney and the liver in fetuses, regulates mammalian erythropoiesis. rHuEPO may also have additional therapeutic effects in vivo, such as recruitment of vascular
Other data
| Title | THE ROLE OF RECOMBINANT HUMAN ERYTHROPOIETIN IN MANAGEMENT OF CRITICALLY ILL PATIENTS | Other Titles | دورعقار الأريثروبويتين البشرى فى علاجمرضى الحالات الحرجة | Authors | Sameh Bashir AL-Hewety | Keywords | THE ROLE OF RECOMBINANT HUMAN ERYTHROPOIETIN IN MANAGEMENT OF CRITICALLY ILL PATIENTS | Issue Date | 2012 | Description | Summary Erythropoietin (EPO) is the principal hematopoietic hormone produced by the kidney and the liver in fetuses, regulates mammalian erythropoiesis. rHuEPO may also have additional therapeutic effects in vivo, such as recruitment of vascular |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 117358g634.pdf | 302.45 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.